As reported in Figure 4C, the contingency analysis through Fisher’s exact test evidenced an extremely significant difference in both YY1 and BIRC5 expression, with an 80% of YY1-High expressing samples and a 70% BIRC5-High expressing samples within the BL subgroup. This evidence concerns the gene BIRC5 and Burkitt lymphoma.